Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Mbio|April 25, 2022
Evidence for an ACE2-Independent Entry Pathway That Can Protect from Neutralization by an Antibody Used for COVID-19 TherapyMarkus Hoffmann, Anzhalika Sidarovich, Prerna Arora, et al.Cell Reports|April 27, 2022
SARS-CoV-2 variants C.1.2 and B.1.621 (Mu) partially evade neutralization by antibodies elicited upon infection or vaccinationPrerna Arora, Amy Kempf, Inga Nehlmeier, et al.Viruses|November 11, 2022
Host Cell Entry and Neutralization Sensitivity of SARS-CoV-2 Lineages B.1.620 and R.1Anzhalika Sidarovich, Nadine Krüger, Cheila Rocha, et al.Journal of Medical Virology|September 3, 2022
Native and activated antithrombin inhibits TMPRSS2 activity and SARS-CoV-2 infectionLukas Wettstein, Patrick Immenschuh, Tatjana Weil, et al.Cell Reports|October 6, 2021
B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccinationPrerna Arora, Anzhalika Sidarovich, Nadine Krüger, et al.Cell Host & Microbe|May 19, 2022
SARS-CoV-2 Omicron sublineages show comparable cell entry but differential neutralization by therapeutic antibodiesPrerna Arora, Lu Zhang, Nadine Krüger, et al.Virology|September 9, 2025
Host cell entry efficiency and neutralization sensitivity of the SARS-CoV-2 MC.10.1 variantLu Zhang, Amy Kempf, Inga Nehlmeier, et al.Vaccines|November 26, 2024
Comparative Analysis of Host Cell Entry Efficiency and Neutralization Sensitivity of Emerging SARS-CoV-2 Lineages KP.2, KP.2.3, KP.3, and LB.1Nianzhen Chen, Katharina Emma Decker, Sebastian R Schulz, et al.Cell|January 13, 2022
The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemicMarkus Hoffmann, Nadine Krüger, Sebastian Schulz, et al.International Journal of Molecular Sciences|November 26, 2022
The SARS-CoV-2 Delta-Omicron Recombinant Lineage (XD) Exhibits Immune-Escape Properties Similar to the Omicron (BA.1) VariantPrerna Arora, Lu Zhang, Cheila Rocha, et al.Pageof 3